NSN 6505-01-434-8622
Part Details | PROPOFOL INJECTION
6505-01-434-8622
Alternate Parts: NDC63323026950, NDC63323-0269-50, 960496, 96-0496, NDC63323026950, NDC63323-0269-50, NDC00409469933, NDC00409-4699-33, NDC00703285809, NDC00703-2858-09, 6505-01-434-8622, 01-434-8622, 6505014348622, 014348622
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | AUG 09, 1996 | 01-434-8622 | 45977 ( PROPOFOL INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-434-8622
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC63323-0269-50 | 4JRB5 | APP PHARMACEUTICALS INC. |
| 96-0496 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC63323-0269-50 | 57KZ6 | FRESENIUS KABI USA, LLC |
| NDC00409-4699-33 | 3VBU6 | HOSPIRA, INC. |
| NDC00703-2858-09 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-434-8622
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY10.000 MILLIGRAMS PROPOFOL |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 20 |
| SPECIAL FEATURES | ALSO CONTAINS 0.005 PCT. DISODIUM EDETATE |
| SUPPLEMENTARY FEATURES | REPLACEMENT FOR NSN 6505-01-355-3607 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PROPOFOL INJECTION 10MG/ML 50ML VIAL 20S |
